Medecine Therapeutique, ISSN 1264-6520, 03/2003, Volume 9, Issue 1-2, pp. 3 - 4
Journal Article
Annals of Internal Medicine, ISSN 0003-4819, 09/2015, Volume 163, Issue 6, pp. 484 - 485
Journal Article
Aide Soignante, ISSN 1166-3413, 02/2010, Issue 114, pp. 20 - 22
Journal Article
Medecine Therapeutique, ISSN 1264-6520, 05/2004, Volume 10, Issue 3, pp. 155 - 162
Journal Article
Journal of Clinical Microbiology, ISSN 0095-1137, 07/2015, Volume 53, Issue 7, pp. 2163 - 2171
The recognition of carbapenemase-producing Enterobacteriaceae (CPE) isolates is a major laboratory challenge, and their inappropriate or delayed detection may...
MALDI-TOF MS | ASSAY | MANAGEMENT | PSEUDOMONAS-AERUGINOSA | MICROBIOLOGY | METALLO-BETA-LACTAMASES | DIFFERENTIATION | IDENTIFICATION | KLEBSIELLA-PNEUMONIAE | RAPID DETECTION | KPC | Hydrolysis | Imipenem - metabolism | Enterobacteriaceae - enzymology | Time Factors | beta-Lactamases - analysis | Bacteriological Techniques - methods | Humans | Sensitivity and Specificity | Anti-Bacterial Agents - metabolism | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization - methods | Bacterial Proteins - analysis | Life Sciences | Human health and pathology | Bacteriology
MALDI-TOF MS | ASSAY | MANAGEMENT | PSEUDOMONAS-AERUGINOSA | MICROBIOLOGY | METALLO-BETA-LACTAMASES | DIFFERENTIATION | IDENTIFICATION | KLEBSIELLA-PNEUMONIAE | RAPID DETECTION | KPC | Hydrolysis | Imipenem - metabolism | Enterobacteriaceae - enzymology | Time Factors | beta-Lactamases - analysis | Bacteriological Techniques - methods | Humans | Sensitivity and Specificity | Anti-Bacterial Agents - metabolism | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization - methods | Bacterial Proteins - analysis | Life Sciences | Human health and pathology | Bacteriology
Journal Article
Gastroenterology, ISSN 0016-5085, 2017, Volume 153, Issue 1, pp. 49 - 52.e5
Circulating mixed cryoglobulins are detected in 40%–60% of patients with hepatitis C virus (HCV) infection, and overt cryoglobulinemia vasculitis (CryoVas)...
Gastroenterology and Hepatology | Autoimmunity | DAA | Treg Cell | Cryoglobulinemia Vasculitis | THERAPY | GASTROENTEROLOGY & HEPATOLOGY | MIXED CRYOGLOBULINEMIA | Prospective Studies | Receptors, CXCR5 - analysis | Hepatitis C - drug therapy | Humans | Immunoglobulin M - analysis | Middle Aged | Male | Vasculitis - virology | Cryoglobulinemia - virology | Interleukins - analysis | Cryoglobulins - metabolism | Hepatitis C - blood | T-Lymphocytes, Regulatory | Female | Hepatitis C - complications | Imidazoles - therapeutic use | Sofosbuvir - adverse effects | Drug Therapy, Combination | CD4-Positive T-Lymphocytes - chemistry | Sofosbuvir - therapeutic use | Cryoglobulinemia - blood | Vasculitis - blood | Antiviral Agents - therapeutic use | Cryoglobulinemia - drug therapy | Imidazoles - adverse effects | B-Lymphocytes - chemistry | Receptors, Complement 3d - analysis | Antiviral Agents - adverse effects | Vasculitis - drug therapy | Lymphocyte Count | Th17 Cells | Sustained Virologic Response | Rheumatoid factor | Care and treatment | Vasculitis | Medical examination | Analysis | Interferon | B cells | Biological response modifiers | Hepatitis C virus | Hepatitis C | Health aspects | Blood | Antiviral agents | Life Sciences | Medication | Microbiology and Parasitology | Pharmaceutical sciences | Virology
Gastroenterology and Hepatology | Autoimmunity | DAA | Treg Cell | Cryoglobulinemia Vasculitis | THERAPY | GASTROENTEROLOGY & HEPATOLOGY | MIXED CRYOGLOBULINEMIA | Prospective Studies | Receptors, CXCR5 - analysis | Hepatitis C - drug therapy | Humans | Immunoglobulin M - analysis | Middle Aged | Male | Vasculitis - virology | Cryoglobulinemia - virology | Interleukins - analysis | Cryoglobulins - metabolism | Hepatitis C - blood | T-Lymphocytes, Regulatory | Female | Hepatitis C - complications | Imidazoles - therapeutic use | Sofosbuvir - adverse effects | Drug Therapy, Combination | CD4-Positive T-Lymphocytes - chemistry | Sofosbuvir - therapeutic use | Cryoglobulinemia - blood | Vasculitis - blood | Antiviral Agents - therapeutic use | Cryoglobulinemia - drug therapy | Imidazoles - adverse effects | B-Lymphocytes - chemistry | Receptors, Complement 3d - analysis | Antiviral Agents - adverse effects | Vasculitis - drug therapy | Lymphocyte Count | Th17 Cells | Sustained Virologic Response | Rheumatoid factor | Care and treatment | Vasculitis | Medical examination | Analysis | Interferon | B cells | Biological response modifiers | Hepatitis C virus | Hepatitis C | Health aspects | Blood | Antiviral agents | Life Sciences | Medication | Microbiology and Parasitology | Pharmaceutical sciences | Virology
Journal Article
Annals of internal medicine, ISSN 0003-4819, 09/2015, Volume 163, Issue 6, pp. 484 - 485
Journal Article
Blood, ISSN 0006-4971, 04/2015, Volume 125, Issue 14, pp. 2200 - 2205
It is common practice in many centers to offer antithrombotic medications to women with unexplained recurrent miscarriage, in the presence or absence of...
SYSTEM | WOMEN | IN-VITRO | THROMBOMODULIN | LOW-DOSE ASPIRIN | MOLECULAR-WEIGHT HEPARIN | THROMBOPHILIA | THROMBOPROPHYLAXIS | PREGNANCY LOSS | HEMATOLOGY | Anticoagulants | Prognosis | Double-Blind Method | Follow-Up Studies | Humans | Live Birth | Enoxaparin - therapeutic use | Gestational Age | Heparin, Low-Molecular-Weight | Pregnancy | Adult | Female | Abortion, Habitual - prevention & control | Pregnancy Complications - prevention & control | Life Sciences | Human health and pathology | Clinical Trials and Observations
SYSTEM | WOMEN | IN-VITRO | THROMBOMODULIN | LOW-DOSE ASPIRIN | MOLECULAR-WEIGHT HEPARIN | THROMBOPHILIA | THROMBOPROPHYLAXIS | PREGNANCY LOSS | HEMATOLOGY | Anticoagulants | Prognosis | Double-Blind Method | Follow-Up Studies | Humans | Live Birth | Enoxaparin - therapeutic use | Gestational Age | Heparin, Low-Molecular-Weight | Pregnancy | Adult | Female | Abortion, Habitual - prevention & control | Pregnancy Complications - prevention & control | Life Sciences | Human health and pathology | Clinical Trials and Observations
Journal Article
Blood, ISSN 0006-4971, 06/2012, Volume 119, Issue 25, pp. 5996 - 6004
Data on the clinical spectrum and therapeutic management of noninfectious mixed cryoglobulinemia vasculitis (CryoVas) in the era of hepatitis C virus screening...
SURVIVAL | INTERFERON-ALPHA | VIRUS-INFECTION | THERAPY | RITUXIMAB | OCCULT HEPATITIS-C | MARGINAL STRUCTURAL MODELS | RIBAVIRIN | HEMATOLOGY | Infection - therapy | Vasculitis - epidemiology | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Male | Data Collection | Cryoglobulinemia - complications | Vasculitis - complications | Cryoglobulinemia - epidemiology | Infection - epidemiology | Female | Retrospective Studies | Vasculitis - therapy | Cryoglobulinemia - therapy | Rituximab | Treatment Outcome | Combined Modality Therapy | Adrenal Cortex Hormones - adverse effects | Algorithms | Antibodies, Monoclonal - administration & dosage | Aged | Antibodies, Monoclonal, Murine-Derived - adverse effects | Infection - complications | Adrenal Cortex Hormones - administration & dosage | Cohort Studies | Cryoglobulinemia | Antibodies, Monoclonal, Murine-Derived | Adrenal Cortex Hormones | Antibodies, Monoclonal | Infection | Life Sciences | Vasculitis
SURVIVAL | INTERFERON-ALPHA | VIRUS-INFECTION | THERAPY | RITUXIMAB | OCCULT HEPATITIS-C | MARGINAL STRUCTURAL MODELS | RIBAVIRIN | HEMATOLOGY | Infection - therapy | Vasculitis - epidemiology | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Male | Data Collection | Cryoglobulinemia - complications | Vasculitis - complications | Cryoglobulinemia - epidemiology | Infection - epidemiology | Female | Retrospective Studies | Vasculitis - therapy | Cryoglobulinemia - therapy | Rituximab | Treatment Outcome | Combined Modality Therapy | Adrenal Cortex Hormones - adverse effects | Algorithms | Antibodies, Monoclonal - administration & dosage | Aged | Antibodies, Monoclonal, Murine-Derived - adverse effects | Infection - complications | Adrenal Cortex Hormones - administration & dosage | Cohort Studies | Cryoglobulinemia | Antibodies, Monoclonal, Murine-Derived | Adrenal Cortex Hormones | Antibodies, Monoclonal | Infection | Life Sciences | Vasculitis
Journal Article
Medicine (United States), ISSN 0025-7974, 03/2013, Volume 92, Issue 2, pp. 61 - 68
Type I cryoglobulinemia vasculitis (CryoVas) is considered a life-threatening condition; however, data on the characteristics and outcome are scarce. To...
SECONDARY | MEDICINE, GENERAL & INTERNAL | THALIDOMIDE | BORTEZOMIB | RITUXIMAB | MANIFESTATIONS | France - epidemiology | Vasculitis - epidemiology | Cryoglobulinemia - drug therapy | Humans | Middle Aged | Vasculitis - etiology | Lymphoproliferative Disorders - complications | Male | Treatment Outcome | Cryoglobulinemia - complications | Cryoglobulinemia - epidemiology | Vasculitis - drug therapy | Aged, 80 and over | Adult | Female | Aged | Antimitotic agents | Usage | Cryoglobulinemia | Care and treatment | Prognosis | Diagnosis | Antineoplastic agents | Health aspects | Statistics | Risk factors | Lymphoproliferative Disorders | Life Sciences | Vasculitis | France | Original Study
SECONDARY | MEDICINE, GENERAL & INTERNAL | THALIDOMIDE | BORTEZOMIB | RITUXIMAB | MANIFESTATIONS | France - epidemiology | Vasculitis - epidemiology | Cryoglobulinemia - drug therapy | Humans | Middle Aged | Vasculitis - etiology | Lymphoproliferative Disorders - complications | Male | Treatment Outcome | Cryoglobulinemia - complications | Cryoglobulinemia - epidemiology | Vasculitis - drug therapy | Aged, 80 and over | Adult | Female | Aged | Antimitotic agents | Usage | Cryoglobulinemia | Care and treatment | Prognosis | Diagnosis | Antineoplastic agents | Health aspects | Statistics | Risk factors | Lymphoproliferative Disorders | Life Sciences | Vasculitis | France | Original Study
Journal Article
Reproductive BioMedicine Online, ISSN 1472-6483, 08/2019, Volume 39, Issue 2, pp. 304 - 311
Is blood anti-Müllerian hormone (AMH) concentration a strong determinant of unexplained recurrent early miscarriage (REM)? In the first part of the study, AMH...
Recurrent miscarriage | Anti-Müllerian hormone | Fertile women | Case–control study | Prospective cohort study | Ovarian reserve | TESTS | Case-control study | PREGNANCY LOSS | Anti-Mullerian hormone | OBSTETRICS & GYNECOLOGY | WOMEN | REPRODUCTIVE BIOLOGY | DIMINISHED OVARIAN RESERVE | ANTIMULLERIAN HORMONE
Recurrent miscarriage | Anti-Müllerian hormone | Fertile women | Case–control study | Prospective cohort study | Ovarian reserve | TESTS | Case-control study | PREGNANCY LOSS | Anti-Mullerian hormone | OBSTETRICS & GYNECOLOGY | WOMEN | REPRODUCTIVE BIOLOGY | DIMINISHED OVARIAN RESERVE | ANTIMULLERIAN HORMONE
Journal Article
Chest, ISSN 0012-3692, 2012, Volume 141, Issue 2, pp. 381 - 387
Background Planar ventilation/perfusion ( ) lung scintigraphy is a validated tool for the diagnosis of pulmonary embolism (PE). Nevertheless, given the high...
Pulmonary/Respiratory | PROBABILITY | MANAGEMENT | RESPIRATORY SYSTEM | SCINTIGRAPHY | CLINICAL-MODEL | PERFUSION SCAN | THROMBOEMBOLISM | PLANAR | COMPUTED-TOMOGRAPHY | NONINVASIVE DIAGNOSIS | SPECT | CRITICAL CARE MEDICINE | Prevalence | Prospective Studies | Humans | Middle Aged | Tomography, Emission-Computed, Single-Photon | Male | Pulmonary Embolism - epidemiology | Adolescent | Aged, 80 and over | Adult | Female | Aged | Pulmonary Embolism - diagnostic imaging | Pulmonary embolism | Ventilation-perfusion ratio | Usage | SPECT imaging | Diagnosis | Research | Life Sciences | Human health and pathology | Pulmonary Embolism
Pulmonary/Respiratory | PROBABILITY | MANAGEMENT | RESPIRATORY SYSTEM | SCINTIGRAPHY | CLINICAL-MODEL | PERFUSION SCAN | THROMBOEMBOLISM | PLANAR | COMPUTED-TOMOGRAPHY | NONINVASIVE DIAGNOSIS | SPECT | CRITICAL CARE MEDICINE | Prevalence | Prospective Studies | Humans | Middle Aged | Tomography, Emission-Computed, Single-Photon | Male | Pulmonary Embolism - epidemiology | Adolescent | Aged, 80 and over | Adult | Female | Aged | Pulmonary Embolism - diagnostic imaging | Pulmonary embolism | Ventilation-perfusion ratio | Usage | SPECT imaging | Diagnosis | Research | Life Sciences | Human health and pathology | Pulmonary Embolism
Journal Article
BMC Infectious Diseases, ISSN 1471-2334, 07/2018, Volume 18, Issue 1, pp. 302 - 10
Background: To describe extra-haematological manifestations associated with human parvovirus B19 (HPV-B19) infection. Methods: We conducted a nationwide...
Glomerulonephritis | Arthritis | Vasculitis | Human parvovirus B19 | Intravenous immunoglobulin, lupus | Peripheral neuropathy | ANTIBODIES | INFECTIOUS DISEASES | INVOLVEMENT | Intravenous immunoglobulin | INTRAVENOUS IMMUNOGLOBULIN THERAPY | lupus | HEPATITIS | DISEASE | CHRONIC-FATIGUE-SYNDROME | OF-THE-LITERATURE | BIOLOGICAL MANIFESTATIONS | RED-CELL APLASIA | Parvovirus B19, Human | Prospective Studies | Parvoviridae Infections - physiopathology | Humans | Middle Aged | Male | Arthritis, Rheumatoid | Pregnancy Complications, Infectious - physiopathology | Pregnancy | Young Adult | Aged, 80 and over | Adult | Female | Aged | Retrospective Studies | Immunoglobulins, Intravenous | Complications and side effects | Care and treatment | Diagnosis | Research | Parvovirus infections | Lupus | Edema | Immunoglobulins | Hematology | Blood & organ donations | Infections | Patients | Chronic fatigue syndrome | Human papillomavirus | Biopsy | Adults | Sickle cell disease | Deoxyribonucleic acid--DNA | Life Sciences | Human health and pathology | Infectious diseases
Glomerulonephritis | Arthritis | Vasculitis | Human parvovirus B19 | Intravenous immunoglobulin, lupus | Peripheral neuropathy | ANTIBODIES | INFECTIOUS DISEASES | INVOLVEMENT | Intravenous immunoglobulin | INTRAVENOUS IMMUNOGLOBULIN THERAPY | lupus | HEPATITIS | DISEASE | CHRONIC-FATIGUE-SYNDROME | OF-THE-LITERATURE | BIOLOGICAL MANIFESTATIONS | RED-CELL APLASIA | Parvovirus B19, Human | Prospective Studies | Parvoviridae Infections - physiopathology | Humans | Middle Aged | Male | Arthritis, Rheumatoid | Pregnancy Complications, Infectious - physiopathology | Pregnancy | Young Adult | Aged, 80 and over | Adult | Female | Aged | Retrospective Studies | Immunoglobulins, Intravenous | Complications and side effects | Care and treatment | Diagnosis | Research | Parvovirus infections | Lupus | Edema | Immunoglobulins | Hematology | Blood & organ donations | Infections | Patients | Chronic fatigue syndrome | Human papillomavirus | Biopsy | Adults | Sickle cell disease | Deoxyribonucleic acid--DNA | Life Sciences | Human health and pathology | Infectious diseases
Journal Article
BMJ Open, ISSN 2044-6055, 03/2019, Volume 9, Issue 3, p. e025649
IntroductionRecurrent miscarriage (RM), defined by three or more consecutive losses during the first trimester of pregnancy, affects 1%–2% of fertile couples....
subfertility | internal medicine | clinical trials | WOMEN | MEDICINE, GENERAL & INTERNAL | SYSTEMIC-LUPUS-ERYTHEMATOSUS | ANTIMALARIAL-DRUGS | UNEXPLAINED PREGNANCY LOSS | RISK-FACTORS | DEEP VENOUS THROMBOSIS | MOLECULAR-WEIGHT HEPARIN | ANTIPHOSPHOLIPID ANTIBODIES | TNF-ALPHA | ASPIRIN | Lupus | Immunoglobulins | Cytokines | Clinical trials | Systematic review | Arthritis | Gene expression | Thrombosis | Prevention | Pregnancy | Womens health | Surgery | Tumor necrosis factor-TNF | Miscarriage | Drug dosages | Life Sciences | Human health and pathology | Gynecology and obstetrics
subfertility | internal medicine | clinical trials | WOMEN | MEDICINE, GENERAL & INTERNAL | SYSTEMIC-LUPUS-ERYTHEMATOSUS | ANTIMALARIAL-DRUGS | UNEXPLAINED PREGNANCY LOSS | RISK-FACTORS | DEEP VENOUS THROMBOSIS | MOLECULAR-WEIGHT HEPARIN | ANTIPHOSPHOLIPID ANTIBODIES | TNF-ALPHA | ASPIRIN | Lupus | Immunoglobulins | Cytokines | Clinical trials | Systematic review | Arthritis | Gene expression | Thrombosis | Prevention | Pregnancy | Womens health | Surgery | Tumor necrosis factor-TNF | Miscarriage | Drug dosages | Life Sciences | Human health and pathology | Gynecology and obstetrics
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 03/2013, Volume 72, Issue 3, pp. 374 - 380
Background Data on the prognosis of non-infectious mixed cryoglobulinaemia vasculitis (CryoVas) in the era of hepatitis C virus screening are lacking. Methods...
CHURG-STRAUSS-SYNDROME | SYSTEMIC VASCULITIS | HEPATITIS-C VIRUS | MODELS | TERM-FOLLOW-UP | POLYARTERITIS-NODOSA | RHEUMATOLOGY | FEATURES | Severity of Illness Index | Prognosis | Area Under Curve | Humans | Middle Aged | Vasculitis - etiology | Kaplan-Meier Estimate | Male | Data Collection | Cryoglobulinemia - mortality | Cryoglobulinemia - complications | Vasculitis - mortality | Genetic Diseases, Inborn - complications | Female | Aged | Retrospective Studies | Genetic Diseases, Inborn - mortality | Cryoglobulinemia | Kidney failure | Patient outcomes | Gastrointestinal system | Lung diseases | Health aspects | Variables | Hepatitis | Immunoglobulins | Disease | Medical prognosis | Mortality | Ulcers | Clinical trials | Lymphomas | Infections | Age | Genetic Diseases, Inborn | Life Sciences | Vasculitis
CHURG-STRAUSS-SYNDROME | SYSTEMIC VASCULITIS | HEPATITIS-C VIRUS | MODELS | TERM-FOLLOW-UP | POLYARTERITIS-NODOSA | RHEUMATOLOGY | FEATURES | Severity of Illness Index | Prognosis | Area Under Curve | Humans | Middle Aged | Vasculitis - etiology | Kaplan-Meier Estimate | Male | Data Collection | Cryoglobulinemia - mortality | Cryoglobulinemia - complications | Vasculitis - mortality | Genetic Diseases, Inborn - complications | Female | Aged | Retrospective Studies | Genetic Diseases, Inborn - mortality | Cryoglobulinemia | Kidney failure | Patient outcomes | Gastrointestinal system | Lung diseases | Health aspects | Variables | Hepatitis | Immunoglobulins | Disease | Medical prognosis | Mortality | Ulcers | Clinical trials | Lymphomas | Infections | Age | Genetic Diseases, Inborn | Life Sciences | Vasculitis
Journal Article